VelosBio

VelosBio is an oncology company, developing novel antibody-drug conjugates to treat hematological cancers. The company was acquired by Merck in November 2020.

Overview Structured Data Issues Contributors

All edits by Megan Gustafson

Edits on 20 Feb, 2024

Megan Gustafson

edited on 20 Feb, 2024

Edits made to:

Infobox (-4 properties)

Infobox

Instagram URL

https://www.instagram.com/merck

YouTube Channel

https://www.youtube.com/user/Merck

Facebook URL

https://www.facebook.com/MerckInvents

Twitter URL

https://twitter.com/Merck

Megan Gustafson

edited on 20 Feb, 2024

Edits made to:

Description (+158 characters)

VelosBio

VelosBio is an oncology company, developing novel antibody-drug conjugates to treat hematological cancers. The company was acquired by Merck in November 2020.

Find more companies like VelosBio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.